Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016

Author:

Cassim NaseemORCID,Rebbeck Timothy R,Glencross Deborah K,George Jaya A

Abstract

ObjectivesThe objective of our study was to use laboratory data to describe prostate-specific antigen (PSA) testing trends for primary healthcare (PHC) services from a single province. PHC is a basic package of services offered to local communities, serving as the first point of contact within the health system. These services are offered at clinics and community health centres (CHC), the latter providing additional maternity, accident and emergency services.DesignThe retrospective descriptive study design was used.MethodsWe analysed national laboratory data between 2006 and 2016 for men ≥30 years in the Gauteng Province. We used the probabilistic matching algorithm to create first-ever PSA cohort. We used the hot-deck imputation to assign missing race group values and the district health information system facility descriptors to identify PHC testing. We reported patient numbers by calendar year, age category and race group as well as descriptive statistics. We used multivariable logistic regression to assess any association for race group and age with a PSA ≥4 µg/L.ResultsBetween 2006 and 2016, numbers of men tested increased from 1782 to 67 025, respectively, with 186 984/239 506 (78.1%) tests were from clinics. The majority of testing was for men in the 50–59 age category (31.5%) and Black Africans (86.4%). We reported a median of 0.9 µg/L that increased with age. A PSA ≥4 µg/L was reported for 11.7% of men, increasing to 35.5% for the ≥70 age category. The logistic regression reported that the adjusted odds of having a PSA ≥4 µg/L was significantly lower for Indian/Asians, multiracials and whites than for Black Africans (p value<0.0001).ConclusionsOur study has shown a marked increase in PSA testing from clinics and CHC suggestive of screening for prostate cancer. The approaches reported in this study can be extended for national data.

Funder

National Cancer Institute

Publisher

BMJ

Subject

General Medicine

Reference54 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. International Agency for Research on Cancer (IARC) . GLOBOCAN cancer fact sheets: prostate cancer. Geneva, Switzerland: International Agency for Research on Cancer (IARC), 2012. http://globocan.iarc.fr/old/FactSheets/cancers/prostate-new.asp

3. An estimate of the incidence of prostate cancer in Africa: a systematic review and meta-analysis;Adeloye;PLoS One,2016

4. National Cancer Registry . Summary statistics of cancer diagnosed histologically in South Africa in 2014. Johannesburg, South Africa: National Institute for Occupational Health (NIOH), 2014. http://www.nicd.ac.za/wp-content/uploads/2017/03/2014-NCR-tables-1.pdf

5. European Association of Urology . Guidelines on prostate cancer. Aarnheim, Netherlands: European Association of Urology, 2016. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Prostate-Cancer-2016.pdf

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3